Abstract 4645: CIP2A is a marker of reduced survival in serous ovarian cancer patients

@article{Bckelman2010Abstract4C,
  title={Abstract 4645: CIP2A is a marker of reduced survival in serous ovarian cancer patients},
  author={Camilla B{\"o}ckelman and Heini Lassus and Annabrita Hemmes and Arto Leminen and Jukka Westermarck and Caj Haglund and Ralf B{\"u}tzow and Ari Ristim{\"a}ki},
  journal={Cancer Research},
  year={2010},
  volume={70},
  pages={4645-4645},
  url={https://api.semanticscholar.org/CorpusID:72076708}
}
The results show that CIP2A protein expression is a novel marker of reduced survival in patients with serous ovarian carcinoma, and suggest that C IP2A characterizes the aggressive type of this disease even within subgroups with initially favorable prognosis.
View via Publisher
1 Citation

One Citation

CIP2A Influences Survival in Colon Cancer and Is Critical for Maintaining Myc Expression

It is found that CIP2A serves as an independent prognostic marker for disease-free and overall survival and was found to be dependent on MAPK activity, linking elevated c-Myc expression to deregulated signal transduction in colon cancer.